Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -404,793 | -206,031 | -784,955 | -601,924 | -295,746 |
| Depreciation Amortization | 7,009 | 3,378 | 10,125 | 7,264 | 4,585 |
| Accounts receivable | -6,668 | 10,937 | -1,114 | 14,842 | 8,240 |
| Accounts payable and accrued liabilities | 1,549 | 1,519 | 2,663 | 2,972 | -3,626 |
| Other Working Capital | -25,460 | -219 | -35,628 | -33,783 | -56,314 |
| Other Operating Activity | 123,066 | 44,959 | 298,900 | 243,271 | 83,008 |
| Operating Cash Flow | $-305,297 | $-145,457 | $-510,009 | $-367,358 | $-259,853 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,264 | -5,930 | -24,807 | -19,163 | -9,809 |
| Purchase Of Investment | -833,781 | -106,516 | -1,068,173 | -722,523 | -387,071 |
| Sale Of Investment | 482,539 | 257,938 | 1,109,646 | 829,544 | 555,717 |
| Investing Cash Flow | $-361,506 | $145,492 | $16,666 | $87,858 | $158,837 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 729,460 | 729,460 | N/A |
| Debt Repayment | -6,543 | -2,735 | -413,513 | -410,791 | -5,582 |
| Common Stock Issued | 760,149 | 11,346 | N/A | N/A | N/A |
| Other Financing Activity | 47,021 | -841 | 208,511 | 95,084 | 88,869 |
| Financing Cash Flow | $800,627 | $7,770 | $524,458 | $413,753 | $83,287 |
| Exchange Rate Effect | -1,078 | -483 | -715 | -906 | -952 |
| Beginning Cash Position | 125,632 | 125,632 | 95,232 | 95,232 | 95,232 |
| End Cash Position | 258,378 | 132,954 | 125,632 | 228,579 | 76,551 |
| Net Cash Flow | $132,746 | $7,322 | $30,400 | $133,347 | $-18,681 |
| Free Cash Flow | |||||
| Operating Cash Flow | -305,297 | -145,457 | -510,009 | -367,358 | -259,853 |
| Capital Expenditure | -10,264 | -5,930 | -24,807 | -19,163 | -9,809 |
| Free Cash Flow | -315,561 | -151,387 | -534,816 | -386,521 | -269,662 |